PET scanning is giving Mass General Hospital researchers a whole new view of neurodegenerative diseases. Previously, definitive diagnoses of these diseases could only be achieved by post-mortem pathological exam.
Departments, Centers, & Programs:
Neurology & Stroke Services
15 Parkman Street
Boston, MA 02114-3117
- M.D.; Ph.D., UC San Francisco School of Medicine
- University of California, San Franciso
- Residency, Brigham and Women's Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Gomperts's clinical and basic research focuses on Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. In human studies, he explores the disease processes responsible for Parkinson's disease, dementia with Lewy bodies, and the related diseases progressive supranuclear palsy and corticobasal syndrome with brain PET imaging, visualizing pathogenic processes, such as the accumulation of beta-amyloid and tau and the loss of dopamine neurons projecting to brain regions that subserve cognition. In animal models, he uses pharmacology, multi-electrode recordings of brain cell activity, and optogenetic tools to investigate normal brain function and develop strategies to restore brain function in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.